Obesity, Appetite Control & Diabetes
Obesity, Appetite Control & Diabetes(肥胖，食欲控制 & 糖尿病)
Obesity, Appetite Control & Diabetes
Satiety, appetite, and craving are CNS drives, whereas metabolism and energy utilization are peripheral endocrine actions.
Stephen M. Stahl, M.D., Ph.D. read more
Obesity, Appetite Control & Diabetes 相关产品(350)
- GC5242810-oxo-12(Z)-Octadecenoic Acid-d5纯度: >99.00%
An internal standard for the quantification of 10-oxo-12(Z)-octadecenoic acid
- GC52453Orexin A (17-33) (human, mouse, rat, bovine) (trifluoroacetate salt)纯度: >98.00%
A peptide orexin receptor 1 agonist
- GC52507Orexin A amide (bovine, human, mouse, rat) (trifluoroacetate salt)纯度: >95.00%
A hypothalamic neuropeptide
- GC60997Lixisenatide acetateCAS: 1997361-87-1纯度: >98.50%
Lixisenatideacetate是胰高血糖素样肽1受体(GLP-1R)的激动剂，可用于2型糖尿病的研究。
- GC72222SurvodutideCAS: 2805997-46-8纯度: >99.00%
Survodutide（BI 456906）是一种强效的选择性胰高血糖素受体/GLP-1受体（GCGR/GLP-1R）双重激动剂，在CHO-K1细胞中的EC50分别为0.52 nM和0.33 nM。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC52428 | 10-oxo-12(Z)-Octadecenoic Acid-d5 | - | >99.00% | |
An internal standard for the quantification of 10-oxo-12(Z)-octadecenoic acid | ||||
| GC52453 | Orexin A (17-33) (human, mouse, rat, bovine) (trifluoroacetate salt) | - | >98.00% | |
A peptide orexin receptor 1 agonist | ||||
| GC52476 | Bax Inhibitor Peptide V5 (trifluoroacetate salt) | - | >98.00% | |
A Bax inhibitor | ||||
| GC52490 | Glucagon (hydrochloride) | 19179-82-9 | >95.00% | |
A peptide hormone | ||||
| GC52493 | Glucosylceramide (bovine buttermilk) | - | >98.00% | |
A sphingolipid | ||||
| GC52496 | Sulfatide (bovine) (sodium salt) | - | >95.00% | |
A mixture of isolated bovine sulfatides | ||||
| GC52497 | Lactosylceramide (porcine RBC) | - | >98.00% | |
A sphingolipid | ||||
| GC52502 | Peptide YY (3-36) (trifluoroacetate salt) | - | >95.00% | |
A satiety hormone | ||||
| GC52504 | Human Vitamin D Receptor Reporter Assay System | - | - | |
A nuclear receptor cell-based reporter assay | ||||
| GC52506 | Ghrelin (human) (trifluoroacetate salt) | - | >98.00% | |
A growth hormone releasing peptide | ||||
| GC52507 | Orexin A amide (bovine, human, mouse, rat) (trifluoroacetate salt) | - | >95.00% | |
A hypothalamic neuropeptide | ||||
| GC60311 | PTUPB | 1287761-01-6 | >99.50% / >98.00% | |
PTUPB是一种新型的COX-2和sEH双抑制剂，IC 50 值分别为 1.26 nM 和 0.9μM。 | ||||
| GC60871 | Gemigliptin tartrate | 1374639-74-3 | >98.00% | |
A DPP-4 inhibitor | ||||
| GC60997 | Lixisenatide acetate | 1997361-87-1 | >98.50% | |
Lixisenatideacetate是胰高血糖素样肽1受体(GLP-1R)的激动剂，可用于2型糖尿病的研究。 | ||||
| GC64119 | Saponarin | 20310-89-8 | - | |
A flavonoid glycoside with diverse biological activities | ||||
| GC69439 | Mazdutide | 2259884-03-0 | >99.00% | |
Mazdutide是一种有长效作用的胰高血糖素样肽-1受体（GLP-1R；K i =28.6nM）和胰高血糖素受体（GCGR；K i =17.7nM）双重激动剂。 | ||||
| GC70855 | LSN3318839 | 2764704-18-7 | >99.00% | |
LSN3318839是一种口服有效的胰高血糖素样肽-1受体(GLP-1R)的阳性变构调节剂。 | ||||
| GC72096 | Bamadutide | 1596343-09-7 | >99.00% | |
Bamadutide（SAR425899）是一种强效的双胰高血糖素样肽-1受体/胰高血糖激素受体激动剂。 | ||||
| GC72222 | Survodutide | 2805997-46-8 | >99.00% | |
Survodutide（BI 456906）是一种强效的选择性胰高血糖素受体/GLP-1受体（GCGR/GLP-1R）双重激动剂，在CHO-K1细胞中的EC50分别为0.52 nM和0.33 nM。 | ||||
| GC90363 | 10(11)-Cl-BBQ | - | >95.00% | |
一种作为AhR激动剂的混合物。 | ||||
| GC90496 | β-Cortolone | 667-66-3 | >95.00% | |
一种皮质醇的代谢产物。 | ||||
| GC90582 | Perfluorooctanesulfonic Acid | 1763-23-1 | >95.00% / >98.00% | |
一种全氟烷基物质 | ||||
| GC90698 | Eicosapentaenoic Acid-d5 ethyl ester | 2483831-19-0 | >99.00% | |
一种用于量化乙酰化二十碳五烯酸乙酯的内部标准。 | ||||
| GC90819 | 2,3,7,8-Tetrachlorodibenzofuran | 51207-31-9 | >90.00% | |
一种多氯二苯并呋喃和二恶英 | ||||